الفهرس 
Portal hypertension
Pathophysiology of portal hypertension:Only 14 pages are availabe for public view
 |  | from | 32 |  |  |
| | | from | 32 | | |
Abstract
Liver cirrhosis is the end stage of chronic liver diseases resulting in life-threatening complications.Portal hypertension is responsible for the more severe and often lethal complications of cirrhosis. The prevalence of esophageal varices (OV) in patients with cirrhosis is variable, ranging from 24% to 80%, with an annual risk of variceal bleeding in about 4% to 15% and a fatal outcome in about 30% of patients during the first episode of bleeding. Gastric varices (GV) are not as common as esophageal varices, they occur in 5–33% of patients with portal hypertension, with a reported incidence of approximately 25% in 2 years. Among patients with GV, concomitant gastro esophageal varices are the most common type and comprise about 80% of this entity. Both endoscopic sclerotherapy and band ligation are very effective in controlling acute OV bleeding and preventing rebleeding during hospitalization The aim of this work is to evaluate a new scleroligation technique in the management of bleeding gastro-esophageal varices in regard to efficacy, complications, variceal recurrence, and survival. The aim of this work is to evaluate a new scleroligation technique in the management of bleeding gastro esophageal varices in regard to efficacy,complications,variceal recurrence, and survival.